Use of Intravenous Tranexamic Acid During Myomectomy
Status:
Completed
Trial end date:
2018-02-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of the early administration of
intravenous (IV) Tranexamic acid (TA) on perioperative bleeding (as defined by measured
intraoperative estimated blood loss (EBL), change in pre and post-operative hemoglobin (Hb),
and frequency of blood transfusions) in women undergoing a myomectomy.